Rating Change
BTIG analysts reiterated a Buy rating on Harrow Health, Inc. (NASDAQ:HROW) on July 21, 2026.
reiterateNASDAQ:HROW
BTIG Reiterates Buy Rating on Harrow Health, Inc. (HROW)
Rating Change BTIG analysts reiterated a Buy rating on Harrow Health, Inc. (NASDAQ:HROW) on July 21, 2026. Market Context Harrow Health, Inc.
Market Context
Harrow Health, Inc. operates in the Healthcare sector. The stock currently trades at $44.68 with a market capitalization of $1.9B.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Harrow Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Harrow Health, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | BTIG | Buy | N/A |
| May 13, 2026 | Cantor Fitzgerald | Overweight | N/A |
| May 12, 2026 | BTIG | Buy | N/A |
| Apr 17, 2026 | BTIG | Buy | N/A |
| Apr 07, 2026 | B. Riley Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View HROW Stock Page
Frequently Asked Questions
What does a Buy rating mean for HROW?
A Buy rating from BTIG reflects the analyst's outlook on Harrow Health, Inc. (NASDAQ:HROW). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HROW forecast page.